Cu6 uses cu64 for diagnostic and cu67 for therapeutic. AT from cu6 is saying that cu64 and cu67 are easily produced and readily available. I have no experience with these so will believe what the company says.
I hold tlx and cu6 but i do hold more tlx because I believe the company can grow faster because it is earning a lot. They can invest a lot in trials. More income coming in years. I hold cu6 because their therapeutic seems interesting though it is at an early stage. Plus Allan from cu6 has a background in investing banking so I believe he will sell the company after a good dosage trial result. Cu6 is only way undervalued if we are talking about a takeover.
TLX will be my long term hold and I believe CB is a very good CEO. Obviously they have great staff otherwise tlx will not be where it is today.
Understanding Telix, page-1402
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.61 |
Change
0.130(0.70%) |
Mkt cap ! $6.227B | |||
| Open | High | Low | Value | Volume |
| $18.69 | $18.80 | $18.37 | $19.72M | 1.061M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 161 | $18.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.62 | 450 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| TLX (ASX) Chart |